Skip to main content

BRCA 2

Image placeholder title
Breast Cancer Treatment

PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.

By Dr. C.H. Weaver M.D.
Image placeholder title
Ovarian Cancer Treatment

Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer

By Dr. C.H. Weaver M.D.
Image placeholder title
Breast Cancer Overviews

Precision Cancer Medicines and Breast Cancer

By Dr. C.H. Weaver M.D.
Prophylactic Mastectomy Breast Cancer
Breast Cancer Treatment

Prophylactic Mastectomy in Women with Genetic Risk of Breast Cancer

By Dr. C.H. Weaver M.D.
CancerConnect CC Green Background 1620x700
Breast Cancer Survivorship

Hereditary Breast and Ovarian Cancer: What you need to know about risk

By Dr. C.H. Weaver M.D.
shutterstock_1226264584
Breast Cancer Overviews

Male BRCA2 Carriers Have Increased Lifetime Risk of Breast Cancer

By Dr. C.H. Weaver M.D.
CHEK2 Gene Mutations Increase Breast Cancer Risk
Breast Cancer

CHEK2 Gene Mutations Increase Breast Cancer Risk

By CancerConnect
Ovarian News & Updates
Ovarian Cancer Survivorship

Genetic Testing For Women at High Risk of Ovarian Cancer

By CancerConnect